Overview

A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This is single dose study of radiolabeled [14C]PF-00299804 in healthy male volunteers to study the absorption, distribution, metabolism and elimination of PF-00299804.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Collaborators:
INC Research
Syneos Health